Deutsch English Français

Contact

EP2757152

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2757152

EP2757152 - METHOD FOR INHIBITING CELL GROWTH, NUCLEIC ACID MOLECULE HAVING RNA INTERFERENCE EFFECT ON NEK10 VARIANT GENE, AND ANTICANCER AGENT [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 29.04.2016 Database last updated on 03.09.2024
Most recent event Tooltip	29.04.2016	Withdrawal of application	published on 01.06.2016 [2016/22]
Applicant(s)	For all designated states Nippon Kayaku Kabushiki Kaisha 11-2, Fujimi 1-chome Chiyoda-ku Tokyo 102-8172 / JP
	[2014/30]
Inventor(s)	01 / SATO, Takamichi c/o Nippon Kayaku Kabushiki Kaisha Pharmaceuticals Research Laboratories 31-12 Shimo 3-chome Kita-ku Tokyo 115-8588 / JP
	[2014/30]
Representative(s)	Andrae Westendorp Patentanwälte Partnerschaft Uhlandstrasse 2 80336 München / DE
	[N/P]
Former [2014/30]	Andrae Westendorp Patentanwälte Partnerschaft Uhlandstrasse 2 80336 München / DE
Application number, filing date	12831615.5	29.08.2012
	WO2012JP71868
Priority number, date	JP20110200756	14.09.2011 Original published format: JP 2011200756
	[2014/30]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013038907
	Date:	21.03.2013
	Language:	JA
	[2013/12]
	Type:	A1 Application with search report
	No.:	EP2757152
	Date:	23.07.2014
	Language:	EN
	[2014/30]
Search report(s)	International search report - published on:	JP	21.03.2013
	(Supplementary) European search report - dispatched on:	EP	03.08.2015
Classification	IPC:	C12N15/00, A61K31/713, A61K48/00, A61P35/00, C12N15/09, C12N15/113, C12Q1/02, C12Q1/68, G01N33/15, G01N33/50	[2014/30]
	CPC:	A61K31/713 (EP,US); A61P35/00 (EP); C12N15/1137 (EP,US); C12Q1/6886 (EP,US); C12Y207/11001 (EP,US); G01N33/5011 (US); (+) G01N33/574 (EP,US); C12N2310/14 (EP,US); C12N2320/34 (US); C12Q2600/106 (US); C12Q2600/158 (EP,US); G01N2500/04 (US); G01N2500/10 (US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/30]
Title	German:	VERFAHREN ZUR ZELLWACHSTUMSHINDERUNG, NUKLEINSÄUREMOLEKÜL MIT RNA-INTERFERENZEFFEKT AUF DAS NEK10-VARIANTEN-GEN UND ANTIKREBSMITTEL	[2014/30]
	English:	METHOD FOR INHIBITING CELL GROWTH, NUCLEIC ACID MOLECULE HAVING RNA INTERFERENCE EFFECT ON NEK10 VARIANT GENE, AND ANTICANCER AGENT	[2014/30]
	French:	PROCÉDÉ D'INHIBITION DE LA CROISSANCE CELLULAIRE, MOLÉCULE D'ACIDE NUCLÉIQUE AYANT L'EFFET D'UN ARN D'INTERFÉRENCE SUR UN VARIANT DU GÈNE NEK10, ET AGENT ANTICANCÉREUX	[2014/30]
Entry into regional phase	24.02.2014	Translation filed
	24.02.2014	National basic fee paid
	24.02.2014	Search fee paid
	24.02.2014	Designation fee(s) paid
	24.02.2014	Examination fee paid
Examination procedure	24.02.2014	Examination requested [2014/30]
	10.02.2016	Amendment by applicant (claims and/or description)
	22.04.2016	Application withdrawn by applicant [2016/22]
Fees paid	Renewal fee
	10.07.2014	Renewal fee patent year 03
	10.08.2015	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XA]WO2004094636 (GALAPAGOS GENOMICS NV [BE], et al) [X] 8-13 * pages 100, 211 * * page 335 * [A] 1-7;
		[Y]JP2005192567 (DAIICHI SEIYAKU CO, et al) [Y] 1-7 * the whole document *;
		[X]US2008113351 (NAITO YUKI [JP], et al) [X] 8-13 * claims 1,7,18,24; sequences 83479, 545324 *;
		[X]WO2009099991 (BRIGHAM & WOMENS HOSPITAL [US], et al) [X] 8-13 * paragraphs [0081] , [0089] , [0090] * * page 127; claim 1 *;
		[X]WO2004045543 (DHARMACON INC [US]) [X] 8-13 * ID number 5015583 ;; claim 1; sequence 1486438
		[XI] - Larissa Moniz, "Characterization of NimA-related Kinase 10 (NEK10): A Role in Checkpoint Control", University of Toronto, Toronto, CA, (20100831), URL: http://hdl.handle.net/1807/24833, (20150316), XP055176698 [X] 8-13 * the whole document * [I] 1-7
		[XA] - DEBRA A. O'LEARY ET AL, "Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening", PLOS ONE, (20091217), vol. 4, no. 12, doi:10.1371/journal.pone.0008348, ISSN 1932-6203, page e8348, XP055083574 [X] 8-13 * page 6, column r - page 8, column l * [A] 1-7 DOI: http://dx.doi.org/10.1371/journal.pone.0008348
		[Y] - MAVADDAT N ET AL, "Genetic susceptibility to breast cancer", MOLECULAR ONCOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 4, no. 3, ISSN 1574-7891, (20100521), pages 174 - 191, (20100521), XP027106316 [Y] 1-7 * page 177; figure 1; table 1 *
		[Y] - R. NASSIRPOUR ET AL, "Nek6 Mediates Human Cancer Cell Transformation and Is a Potential Cancer Therapeutic Target", MOLECULAR CANCER RESEARCH, (20100420), vol. 8, no. 5, doi:10.1158/1541-7786.MCR-09-0291, ISSN 1541-7786, pages 717 - 728, XP055176730 [Y] 1-7 * figures 1,3,4,5; table 1 * DOI: http://dx.doi.org/10.1158/1541-7786.MCR-09-0291
		[A] - O'REGAN LAURA ET AL, "Mitotic regulation by NIMA-related kinases", CELL DIVISION, BIOMED CENTRAL LTD, LO, (20070829), vol. 2, no. 1, doi:10.1186/1747-1028-2-25, ISSN 1747-1028, page 25, XP021030656 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1186/1747-1028-2-25
		[A] - L. O'REGAN ET AL, "The Nek6 and Nek7 Protein Kinases Are Required for Robust Mitotic Spindle Formation and Cytokinesis", MOLECULAR AND CELLULAR BIOLOGY, (20090504), vol. 29, no. 14, doi:10.1128/MCB.01867-08, ISSN 0270-7306, pages 3975 - 3990, XP055176735 [A] 1-7 * figures 5,10 * DOI: http://dx.doi.org/10.1128/MCB.01867-08
		[A] - NOBUYUKI TSUNODA ET AL, "Nek2 as a novel molecular target for the treatment of breast carcinoma", CANCER SCIENCE, (20081127), vol. 100, no. 1, doi:10.1111/j.1349-7006.2008.01007.x, ISSN 1347-9032, pages 111 - 116, XP055176738 [A] 1-7 * figures 1,2,4,5 * DOI: http://dx.doi.org/10.1111/j.1349-7006.2008.01007.x
		[IP] - LARISSA MONIZ ET AL, "Nek family of kinases in cell cycle, checkpoint control and cancer", CELL DIVISION, BIOMED CENTRAL LTD, LO, (20111031), vol. 6, no. 1, doi:10.1186/1747-1028-6-18, ISSN 1747-1028, page 18, XP021114160 [IP] 1-7 * the whole document * DOI: http://dx.doi.org/10.1186/1747-1028-6-18
		[A] - LOH S H Y ET AL, "Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen", CELL DEATH AND DIFFERENTIATION, NATURE PUBLISHING GROUP, GB, vol. 15, no. 2, doi:10.1038/SJ.CDD.4402258, ISSN 1350-9047, (20071116), pages 283 - 298, (20071116), XP002560487 [A] 8-13 * table 2 * DOI: http://dx.doi.org/10.1038/sj.cdd.4402258
	International search	[Y]WO2010094734 (BIOFOCUS DPI B V [NL], et al);
		[A]WO2007117038 (JAPAN FOUND CANCER [JP], et al);
		[A]JP2007282628 (DAIICHI SEIYAKU CO);
		[A]WO2005061704 (TAKEDA PHARMACEUTICAL [JP], et al);
		[A]JP2004203745 (EISAI CO LTD);
		[Y] - MONIZ, L. S. ET AL., "NeklO mediates G2/M cell cycle arrest and MEK autoactivation in response to UV irradiation", MOLECULAR AND CELLULAR BIOLOGY, (201101), vol. 31, no. 1, pages 30 - 42, XP055143033 DOI: http://dx.doi.org/10.1128/MCB.00648-10
		[Y] - "HOMO SAPIENS CDNA FLJ25966 FIS, CLONE TST05207", GENBANK, (20060914), URL: N N N N, XP055148110
		[Y] - LI, J. J. ET AL., "Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis", PHARMACOLOGY & THERAPEUTICS, (2006), vol. 111, pages 74 - 984, XP027900643
		[Y] - BOWERS, A. J. ET AL., "Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors", GENE, (2004), vol. 328, pages 135 - 142, XP004496552 DOI: http://dx.doi.org/10.1016/j.gene.2003.12.002
		[Y] - BELHAM, C. ET AL., "A mitotic cascade of NIMA family kinases", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2003), vol. 278, no. 37, pages 34897 - 34909, XP055143034 DOI: http://dx.doi.org/10.1074/jbc.M303663200
		[Y] - FRY, A. M. ET AL., "A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators", THE EMBO JOURNAL, (1998), vol. 17, no. 2, pages 470 - 481, XP002991357 DOI: http://dx.doi.org/10.1093/emboj/17.2.470
		[Y] - DAVIES, H. ET AL., "Somatic mutations of the protein kinase gene family in human lung cancer", CANCER RES., (2005), vol. 65, no. 17, pages 7591 - 7595, XP002484151
		[Y] - ANTONIOU, A. C. ET AL., "Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction", CANCER RES., (2010), vol. 70, no. 23, pages 9742 - 9754, XP055143035 DOI: http://dx.doi.org/10.1158/0008-5472.CAN-10-1907
		[Y] - AHMED, S. ET AL., "Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2", NATURE GENETICS, (2009), vol. 41, no. 5, pages 585 - 590, XP055143037 DOI: http://dx.doi.org/10.1038/ng.354
		[Y] - MAVADDAT, N. ET AL., "Familial relative risks for breast cancer by pathological subtype: a population-based cohort study", BREAST CANCER RESEARCH, (2010), vol. 12, no. R10, pages 1 - 12, XP021070774
		[Y] - GORODNOVA, T. V. ET AL., "Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women", CANCER GENETICS AND CYTOGENETICS, (2010), vol. 199, pages 69 - 72, XP027020234
		[A] - ZENG, M. ET AL., "Identifying mRNAs bound by human RBMY protein in the testis", JOURNAL OF REPRODUCTION AND DEVELOPMENT, (201103), vol. 57, no. 1, pages 107 - 112, XP055143044 DOI: http://dx.doi.org/10.1262/jrd.10-092N
	by applicant	- M.J. O'CONNELL ET AL., TRENDS IN CELL BIOLOGY, (2003), vol. 13, pages 221 - 228
		- L. O'REGAN ET AL., CELL DIVISION, (2007), vol. 2, pages 25 - 36
		- L.S. MONIZ ET AL., MOLECULAR AND CELLULAR BIOLOGY, (2011), vol. 31, pages 30 - 42
		- S. AHMED ET AL., NATURE GENETICS, (2009), vol. 41, pages 585 - 590
		- A.C. ANTONIOU ET AL., CANCER RESEARCH, (2010), vol. 70, pages 9742 - 9754
		- P. ANTON ET AL., NATURE, (2002), vol. 418, pages 38 - 39
		- L. DAVID ET AL., NAT. GENET., (2002), vol. 32, pages 107 - 108
		- T. R. BRUMMELKAMP ET AL., SCIENCE, (2002), vol. 296, pages 550 - 553
		- N.S. LEE ET AL., NAT. BIOTECH., (2001), vol. 19, pages 500 - 505
		- M. MIYAGISHI; K. TAIRA, NAT. BIOTECH., (2002), vol. 19, pages 497 - 500
		- P.J. PADDISON ET AL., PROC. NATL. ACAD. SCI. USA, (2002), vol. 99, pages 1443 - 1448
		- C.P. PAUL ET AL., NAT. BIOTECH., (2002), vol. 19, pages 505 - 508
		- G. SUI ET AL., PROC. NATL. ACAD. SCI. USA, (2002), vol. 99, pages 5515 - 5520
		- G.M. BARTON; R. MEDZHITOV, PROC. NATL. ACAD. SCI. USA, (2002), vol. 99, pages 14943 - 14945
		- P.J. PADDISON ET AL., GENES DEV., (2002), vol. 16, pages 948 - 958

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p